查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654281

人類偏肺病毒診斷市場規模、佔有率、趨勢分析報告：按技術、最終用途、地區、細分市場預測，2025-2030 年

Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

人類偏肺病毒 (hMPV) 診斷市場的成長和趨勢

根據 Grand View Research, Inc. 的最新報告，全球人類亞肺病毒診斷市場規模預計到 2030 年將達到 9.713 億美元，2025 年至 2030 年的複合年成長率為 10.43%。

由於人類偏肺病毒 (hMPV) 引起的呼吸道感染疾病率不斷上升，尤其是在兒童、老年人和免疫力缺乏低下者等脆弱人群中，人類偏肺病毒診斷市場正在經歷顯著成長。已知 hMPV 會引起呼吸道疾病，包括支氣管炎、肺炎和上呼吸道感染疾病，類似流感和呼吸道融合細胞病毒(RSV) 引起的疾病。人們對 hMPV 在呼吸系統疾病中的作用的認知不斷提高，推動了對有效診斷解決方案的需求，從而促進了市場的擴大。

該市場的主要促進因素是診斷技術的進步、醫療保健支出的增加以及對 hMPV 感染的早期和準確檢測的需求不斷成長。此外，病毒性呼吸道感染疾病的增加，特別是在氣候較溫暖的地區，也是推動成長的一個主要因素。此外，基於 PCR 的檢測、基於抗原的檢測和多重 PCR 平台等快速診斷檢測的持續發展，使得檢測速度更快，這對於改善患者預後和抑制感染傳播至關重要。

hMPV 診斷市場競爭激烈，有幾家主要企業為其成長做出了貢獻。主要市場參與企業包括雅培實驗室、羅氏診斷、賽默飛世爾科技、生物梅里埃和西門子醫療。這些公司正在積極致力於開發新的診斷工具和平台，以更有效地檢測 hMPV。策略聯盟、收購和研發投資幫助我們擴大了產品系列併提高了我們的影響力。

最近的市場趨勢強調了向更先進、快速和更具成本效益的診斷方法的轉變，包括就地檢驗和能夠同時檢測多種病原體的多重分子檢測。這些創新對於滿足日益成長的高效診斷需求至關重要，尤其是在資源有限的環境中。市場也越來越注重開發能夠提供更快結果的測試，以支持及時的治療決策，這對於高風險患者群體至關重要。

hMPV 感染的盛行率在全球呈現上升趨勢，尤其是在5歲以下兒童、老年人和免疫力的患者中。該病毒導致大量患者因呼吸系統疾病住院，已成為重大的公共衛生問題。準確及時的診斷對於有效管理至關重要，診斷解決方案的日益普及預計將繼續塑造 hMPV 診斷市場的未來。

人類偏肺病毒診斷市場報告重點

  • 從技術角度來看，基於 PCR 的診斷領域將在 2024 年佔據最大的收入佔有率，達到 54.97%，這得益於其高準確性、高靈敏度以及檢測低病毒載量的能力。 PCR 檢測能夠在感染早期快速可靠地檢測出 hMPV，從而加快診斷速度、改善患者預後並更有力地控制病毒傳播，尤其是在高風險族群中。
  • 根據最終用途，由於對專門測試、更快的診斷結果和更準確的疾病檢測的需求不斷增加，診斷和參考文獻實驗室部分預計在預測期內以最快的複合年成長率成長。這些實驗室提供識別 hMPV 和其他呼吸道感染疾病的基本服務，為臨床和研究部分提供支援。
  • 根據地區，北美市場預計將主導全球市場，到 2024 年將佔據 41.18% 的收入佔有率。這是由於人們認知度高、醫療基礎設施先進以及呼吸道感染疾病盛行率不斷上升。
  • 人類偏肺病毒診斷市場的競爭十分激烈。主要企業正在採取各種策略，如聯盟、新產品開發、合併、收購和地理擴張，以滿足客戶未滿足的需求。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 全球人類偏肺病毒診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球人類偏肺病毒診斷市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章。

  • 細分儀表板
  • 全球人類偏肺病毒診斷市場技術波動分析
  • 2018 年至 2030 年全球人類偏肺病毒診斷市場規模與趨勢分析（依技術分類）
  • 基於 PCR 的診斷
  • 次世代定序（NGS）
  • 螢光試驗
  • 橫向流動化驗
  • 微陣列技術
  • 其他先進技術

5. 全球人類偏肺病毒診斷市場依最終用途、估計及趨勢分析

  • 細分儀表板
  • 全球人類偏肺病毒診斷市場最終用途變化分析
  • 2018 年至 2030 年全球人類偏肺病毒診斷市場規模及趨勢分析（依最終用途）
  • 醫院和診所
  • 診斷與參考實驗室
  • 學術研究所
  • 其他

6. 人類偏肺病毒診斷市場：區域、估計與趨勢分析

  • 區域控制面板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2023 年企業市場分析
  • 主要認證提供者/計畫所有者列表
  • 公司簡介/上市公司
    • QuidelOrtho Corporation
    • ARUP Laboratories
    • Diasorin
    • R-Biopharm AG
    • Seegene Inc.
    • ZeptoMetrix
    • Abbott
    • Thermo Fisher Scientific Inc.
Product Code: GVR-4-68040-497-3

Human Metapneumovirus Diagnostics Market Growth and Trends:

The global human metapneumovirus diagnostics market size is anticipated to reach USD 971.30 million by 2030 and is projected to grow at a CAGR 10.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. The human metapneumovirus (hMPV) diagnostics market is experiencing significant growth, driven by the increasing prevalence of respiratory infections caused by hMPV, particularly among vulnerable populations such as children, the elderly, and immunocompromised individuals. hMPV is known to cause respiratory illnesses similar to those caused by influenza and respiratory syncytial virus (RSV), including bronchiolitis, pneumonia, and upper respiratory tract infections. As awareness about hMPV's role in respiratory diseases increases, there is a growing demand for effective diagnostic solutions, contributing to the market's expansion.

Key drivers of this market include advancements in diagnostic technologies, rising healthcare spending, and the growing demand for early and accurate detection of hMPV infections. The increasing prevalence of viral respiratory infections, especially in regions with temperate climates, is also a significant factor propelling growth. Furthermore, the ongoing development of rapid diagnostic tests, such as PCR-based assays, antigen-based tests, and multiplex PCR platforms, enables faster detection, which is crucial for improving patient outcomes and controlling the spread of infections.

The hMPV diagnostics market is highly competitive, with several prominent players contributing to its growth. Key market participants include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, BioMerieux, and Siemens Healthineers. These companies are actively involved in developing new diagnostic tools and platforms to detect hMPV more efficiently. Strategic collaborations, acquisitions, and research and development investments are helping them expand their product portfolios and increase their presence.

Recent market trends highlight a shift towards more sophisticated, rapid, and cost-effective diagnostic methods, such as point-of-care testing and multiplex molecular tests that can detect multiple pathogens simultaneously. These innovations are critical in addressing the growing demand for efficient diagnostics, particularly in resource-limited settings. The market is also witnessing an increased focus on developing tests that provide faster results to aid in timely treatment decisions, which is essential for high-risk patient groups.

Prevalence rates of hMPV infections are rising globally, especially in children under five years of age, as well as in the elderly and those with weakened immune systems. The virus is responsible for a substantial number of respiratory hospitalizations, making it a significant public health concern. Accurate and timely diagnosis is crucial for effective management, and the growing adoption of diagnostic solutions is expected to continue to shape the future of the hMPV diagnostics market.

Human Metapneumovirus (hMPV) Diagnostics Market Report Highlights:

  • Based on technology, PCR-based diagnostics segment held the largest revenue share of 54.97% in 2024, driven by its high accuracy, sensitivity, and ability to detect low viral loads. PCR assays enable rapid, reliable detection of hMPV, even in early stages of infection, leading to faster diagnosis, better patient outcomes, and enhanced control of viral transmission, especially in high-risk populations.
  • Based on end use, diagnostic and reference laboratories segment is expected to grow at the fastest CAGR over the forecast period driven by increasing demand for specialized testing, faster diagnostic results, and more accurate disease detection. These laboratories provide essential services for identifying hMPV and other respiratory infections, supporting both clinical and research settings.
  • Based on region, North America market dominated the overall global market and accounted for the 41.18% revenue share in 2024 driven by the increasing due to higher awareness, advanced healthcare infrastructure, and increased prevalence of respiratory infections.
  • The competitive scenario in the Human Metapneumovirus (hMPV) diagnostics market is high. The major companies are undertaking various strategies such as collaborations, new product development, mergers, acquisitions, and geographic expansion for serving the unmet needs of their customers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Human Metapneumovirus (hMPV) Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of respiratory infections
      • 3.2.1.2. Advancements in molecular diagnostic
      • 3.2.1.3. Growing awareness among healthcare providers
      • 3.2.1.4. Supportive regulatory approvals and guidelines
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High costs of advanced diagnostics tests
      • 3.2.2.2. Limited awareness in developing regions
  • 3.3. Global Human Metapneumovirus (hMPV) Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global Human Metapneumovirus (hMPV) Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Human Metapneumovirus (hMPV) Diagnostics Market Technology Movement Analysis
  • 4.3. Global Human Metapneumovirus (hMPV) Diagnostics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. PCR-Based Diagnostics
    • 4.4.1. PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Next-Generation Sequencing (NGS)
    • 4.5.1. Next-Generation Sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6. Immunofluorescence Assays
    • 4.6.1. Immunofluorescence assays market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7. Lateral Flow Assays
    • 4.7.1. Lateral flow assays market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.8. Microarray Technology
    • 4.8.1. Microarray technology market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.9. Other Advanced Technologies
    • 4.9.1. Other advanced technologies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Global Human Metapneumovirus (hMPV) Diagnostics Market: End-use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Human Metapneumovirus (hMPV) Diagnostics Market End-use Movement Analysis
  • 5.3. Global Human Metapneumovirus (hMPV) Diagnostics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals and Clinics
    • 5.4.1. Hospitals and clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diagnostic and Reference Laboratories
    • 5.5.1. Diagnostic and reference laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Academic and Research Institutions
    • 5.6.1. Academic and research institutions market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Metapneumovirus (hMPV) Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. List of Key Certification Providers/Scheme Owners
  • 7.5. Company Profiles/Listing
    • 7.5.1. QuidelOrtho Corporation
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. ARUP Laboratories
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Diasorin
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. R-Biopharm AG
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Seegene Inc.
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. ZeptoMetrix
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Abbott
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Thermo Fisher Scientific Inc.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 Global Human Metapneumovirus (hMPV) diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Europe Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 UK Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 France Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Italy Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Spain Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Sweden Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Denmark Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Norway Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 31 Norway Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Japan Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 36 Japan Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 37 India Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 38 India Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 China Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 40 China Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Australia Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 42 Australia Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 South Korea Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 44 South Korea Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Thailand Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 46 Thailand Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Latin America Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Brazil Human Metapneumovirus (hMPV) diagnostics market, by end-use types, 2018 - 2030 (USD Million)
  • Table 51 Brazil Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Mexico Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 53 Mexico Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Argentina Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 South Africa Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 UAE Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 64 UAE Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Human Metapneumovirus (hMPV) diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Human Metapneumovirus (hMPV) diagnostics market driver analysis
  • Fig. 13 Human Metapneumovirus (hMPV) diagnostics market restraint analysis
  • Fig. 14 Human Metapneumovirus (hMPV) diagnostics market: Porter's analysis
  • Fig. 15 Human Metapneumovirus (hMPV) diagnostics market: PESTLE analysis
  • Fig. 16 Human Metapneumovirus (hMPV) diagnostics market: Technology outlook and key takeaways
  • Fig. 17 Human Metapneumovirus (hMPV) diagnostics market: Technology market share analysis, 2024 - 2030
  • Fig. 18 PCR-based diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 19 Next-Generation Sequencing (NGS) market, 2018 - 2030 (USD Million)
  • Fig. 20 Immunofluorescence assays market, 2018 - 2030 (USD Million)
  • Fig. 21 Lateral flow assays market, 2018 - 2030 (USD Million)
  • Fig. 22 Microarray technology market, 2018 - 2030 (USD Million)
  • Fig. 23 Other advanced technologies market, 2018 - 2030 (USD Million)
  • Fig. 24 Human Metapneumovirus (hMPV) diagnostics market: End-use outlook and key takeaways
  • Fig. 25 Human Metapneumovirus (hMPV) diagnostics market: End-use market share analysis, 2024 - 2030
  • Fig. 26 Hospitals and clinics
  • Fig. 27 Diagnostic and reference laboratories
  • Fig. 28 Academic and research institutions
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace key takeaways
  • Fig. 31 North America Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. key country dynamics
  • Fig. 34 Canada Human Metapneumovirus (hMPV) diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada key country dynamics
  • Fig. 36 Mexico Human Metapneumovirus (hMPV) diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico key country dynamics
  • Fig. 38 Europe Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 UK Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 UK key country dynamics
  • Fig. 41 Germany Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Germany key country dynamics
  • Fig. 43 France Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 France key country dynamics
  • Fig. 45 Italy Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Spain Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Denmark Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Sweden Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Norway Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Asia-Pacific Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Japan key country dynamics
  • Fig. 58 China Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 China key country dynamics
  • Fig. 60 India Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 India key country dynamics
  • Fig. 62 Australia Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Australia key country dynamics
  • Fig. 64 Thailand Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand key country dynamics
  • Fig. 66 South Korea Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea key country dynamics
  • Fig. 68 Latin America Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Argentina Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina key country dynamics
  • Fig. 73 MEA Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa key country dynamics
  • Fig. 76 Saudi Arabia Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia key country dynamics
  • Fig. 78 UAE Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 UAE key country dynamics
  • Fig. 80 Kuwait Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait key country dynamics
  • Fig. 82 Key company categorization
  • Fig. 83 Company market share analysis
  • Fig. 84 Company market position analysis
  • Fig. 85 Market participant categorization
  • Fig. 86 Strategy framework